![Ross Levine](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 30/06/2026
Ross L.
Levine is the founder of Ajax Therapeutics, Inc., founded in 2019, serving as Director since its founding.
Current jobs include Independent Director at Medicus Sciences Acquisition Corp.
since 2021; Member of the Supervisory Board at QIAGEN NV since 2016; Member of the Supervisory Board at QIAGEN GmbH; Professor at Weill Cornell Medical College since 2007; and Member of the Supervisory Board at QIAGEN Srl.
Former jobs include Chief of Molecular Cancer Medicine Services at Memorial Sloan Kettering Cancer Center from 2018 to 2022 and Scientific Advisor at eFFECTOR Therapeutics, Inc. Education includes a doctorate from The Johns Hopkins University School of Medicine and an undergraduate degree from Harvard College.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
QIAGEN NV 0,01 % | 23/01/2026 | 27.495 ( 0,01 % ) | 1 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MEDICUS SCIENCES ACQUISITION CORP. | Director/Miembro de la Junta | 12/02/2021 |
QIAGEN GmbH
 QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services Provides products for preanalytical sample preparation and molecular diagnostics solutions | Director/Miembro de la Junta | - |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2007 |
Qiagen SRL
 Qiagen SRL Medical SpecialtiesHealth Technology Provides molecular testing solutions | Director/Miembro de la Junta | - |
Ajax Therapeutics, Inc.
 Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics | Fundador | 01/01/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| QIAGEN N.V. | Director/Miembro de la Junta | 23/01/2026 |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates cancer hospital | Corporate Officer/Principal | - |
| EFFECTOR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
QIAGEN NV
 QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates cancer hospital | Health Services |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services Provides products for preanalytical sample preparation and molecular diagnostics solutions | Commercial Services |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Qiagen SRL
Qiagen SRL Medical SpecialtiesHealth Technology Provides molecular testing solutions | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ajax Therapeutics, Inc.
Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics | Commercial Services |
Medicus Sciences Acquisition Corp.
 Medicus Sciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
